The omega-3 fatty acids are combined alongside hyaluronic acid and are currently sold in a successful OTC joint care range in the UK. The acids have also demonstrated further potential to treat other indications including asthma, dermatitis and oral health diseases.
The company responsible for developing the fatty acids have full control of the supply chain from extraction right through to product formulation. They are now looking to sell the whole company including the manufacturing factories to a potential partner. Any interested companies should have the relevant development and financial expertise to maintain the current company activities and develop the new product indications.
The client is looking for parties interested in a potential acquisition of the portfolio of companies developing the fatty acids, including the manufacturing bases. Clients focused in the musculoskeletal, respiratory, dermatological or oral health arena would be of particular interest.
Pharmalicensing.com - the leading global resource for partnering, licensing, and business development.View profile
Clients in focus...